Sulong Xiao

Title: Innovations and Contributions of Sulong Xiao

Introduction

Sulong Xiao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of virology, particularly in the development of mutated viruses and adeno-associated viruses. With a total of 3 patents, his work has implications for vaccine development and gene therapy.

Latest Patents

One of his latest patents is titled "Mutant virus, preparation method therefor and application thereof." This invention relates to a mutated virus that can be an influenza virus of human or other animal origin. The method for preparing this mutated virus involves introducing UAG codons into positions upstream of the stop codons of one or more genes of a viral genome using reverse genetic techniques. The applications of this mutated virus include its use as a live attenuated vaccine and in the replication of controllable and safe virus models.

Another significant patent is "Adeno-associated virus with site-directed mutagenesis and site-directed modification and preparation method and application thereof." This invention focuses on an adeno-associated virus that incorporates non-natural amino acids into its capsid protein VP1. This modification allows the virus to couple with other functional molecules and carry functional genes effectively, making it a valuable tool in genetic therapy and research.

Career Highlights

Sulong Xiao has worked at prestigious institutions such as Peking University and the University of Macao. His research has been pivotal in advancing the understanding of viral mechanisms and therapeutic applications.

Collaborations

He has collaborated with notable colleagues, including Demin Zhou and Lihe Zhang, contributing to various research projects and innovations in the field.

Conclusion

Sulong Xiao's innovative work in virology and his patents reflect his commitment to advancing medical science. His contributions have the potential to impact vaccine development and gene therapy significantly.